Knauf Insulation v. Johns Manville: Defendant Wins 9-Year Insulation Binder Patent Battle
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Knauf Insulation LLC, et al. v. Johns Manville Corporation, et al. |
| Case Number | 1:15-cv-00111 (S.D. Ind.) |
| Court | U.S. District Court for the Southern District of Indiana |
| Duration | Jan 2015 – Aug 2024 9 years 6 months |
| Outcome | Defendant Win — All Infringement Claims Defeated |
| Patents at Issue | |
| Accused Products | Johns Manville’s Biobased Binder Insulation Products (e.g., EasyFit, ComfortTherm) |
Case Overview
The Parties
⚖️ Plaintiff
A global manufacturer of insulation products and part of the Knauf Group, holding a significant portfolio of patents covering ecofriendly, formaldehyde-free binder technologies for glass mineral wool insulation.
🛡️ Defendant
A subsidiary of Berkshire Hathaway and major U.S. producer of insulation and roofing materials, whose biobased binder product lines were targeted by Knauf’s infringement claims.
The Patents at Issue
This prolonged case involved six utility patents and one design patent covering formaldehyde-free glass wool insulation binder technology, a pivotal area in green building materials. These patents collectively cover the chemistry and manufacturing methods underlying the shift from formaldehyde-containing to ecofriendly, biobased binder systems.
- • U.S. Patent 8,114,210 — Biobased binder compositions for glass wool
- • U.S. Patent 8,940,089 — Formaldehyde-free binder technology
- • U.S. Patent D631,670 — Design patent for insulation product appearance
- • U.S. Patent 9,039,827 — Binder formulation processes
- • U.S. Patent 9,464,207 — Curable binder compositions
- • U.S. Patent 9,926,464 — Extended binder chemistry claims
Developing a new building material?
Check if your insulation binder design might infringe these or related patents before launch.
The Verdict & Legal Analysis
Outcome
The court entered final judgment for Johns Manville on all six actively litigated patent counts. Knauf’s infringement claims under the Fifth Amended Complaint were adjudicated against it. The specific damages amount was not disclosed in the final judgment, and remaining claims and counterclaims were resolved through settlement and joint dismissal with prejudice.
Key Legal Issues
The judgment’s structure, entering judgment against Knauf on all infringement counts, indicates that Johns Manville successfully defeated Knauf’s infringement assertions across the full patent portfolio. JM’s defense likely pursued a multi-vector strategy combining claim construction arguments (narrowing the scope of Knauf’s claims to exclude JM’s biobased binder formulations), invalidity challenges through USPTO inter partes review proceedings, and direct non-infringement defenses demonstrating that JM’s product chemistry fell outside the asserted claims.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in the building materials industry. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this technology space
- See which companies are most active in biobased binders
- Understand claim construction patterns for chemical formulations
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Biobased binder formulations
6 Patents Litigated
In insulation binder technology
Technical Differentiation Key
Critical for non-infringement defense
✅ Key Takeaways
A large patent portfolio does not overcome claim construction outcomes that exclude accused product formulations — claim scope precision is paramount.
Search related case law →Multi-firm defense teams combining national IP specialists with local counsel are increasingly standard in high-stakes chemistry patent disputes.
Explore precedents →Dismissal with prejudice of bad faith counterclaims via settlement preserves negotiating flexibility on peripheral issues.
Explore litigation strategies →Frequently Asked Questions
Six utility patents (U.S. Patents 8,114,210; 8,940,089; 9,039,827; 9,464,207; 9,926,464) and one design patent (D631,670) were litigated to final judgment, with additional patents resolved through settlement.
The court entered judgment against Knauf on all infringement counts in the Fifth Amended Complaint. Specific claim construction and invalidity findings were not detailed in the final judgment order; remaining claims resolved through settlement and joint dismissal with prejudice.
The outcome signals that defendants with independently developed biobased binder formulations and well-resourced litigation teams can defeat broad chemistry patent portfolios, reinforcing the importance of precise claim drafting and robust technical differentiation for all parties in this space.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- PACER Case Locator — Case No. 1:15-cv-00111 (S.D. Ind.)
- USPTO Patent Full-Text Database
- U.S. Patent and Trademark Office — Patent Resources
- Cornell Legal Information Institute
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.